B cell-driven HIV type 1 expression in T cells: An essential role of CD86 costimulatory molecule

AIDS Research and Human Retroviruses

Volumn 14, Issue 11, 1998, Pages 989-997

  Krzysiek, Roman ^a   Lefèvre, Eric A ^a   Legendre, Christophe ^b   Treton, Dominique ^a   Dormont, Dominique ^b   Galanaud, Pierre ^a   Gras, Gabriel ^b   Richard, Yolande ^a  

^a INSERM   (France)

^b INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD86 ANTIGEN; MONOCLONAL ANTIBODY;

ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE PROLIFERATION; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS REPLICATION;

EID: 0032551630     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1998.14.989     Document Type: Article

References (48)

1. Wain-Hobson S: Virological mayhem. Nature (London) 1995; 373:102.
2. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BH, Saag MS, and Shaw GM: Viral dynamics in human immunodeficiency virus type 1 infection. Nature (London) 1995;373:117-122.
3. Piatak M Jr, Saag MS, Yang LC, Clark SJ, Kappes JC, Luk KC, Hahn BH, Shaw GM, and Lifson JD: High levels of HlV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993;259:1749-1754.
4. Pantaleo G, Graziosi C, Demarest JF, Butini L, Montroni M, Fox CH, Orenstein JM, Kotler DP, and Fauci AS: HIV-1 infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature (London) 1993;362:355-358.
5. Embretson J, Zupancic M, Ribas JL, Burke A, Racz P, Tenner-Racz K, and Haase AT: Massive covert infection of helper T lymphocytes and macrophages by HIV-1 during the incubation period of AIDS. Nature (London) 1993;362:359-362.
6. Fox CH, Tenner-Racz K, Firpo A, Pizzo PA, and Fauci AS: Lymphoid germinal centers are reservoirs of human immunodeficiency virus type 1 RNA. J Infect Dis 1991;164:1051-1057.
7. Biberfeld P, Chayt KJ, Marselle LM, Biberfeld G, Gallo RC, and Harper ME: HTLV-III expression in infected lymph nodes and relevance to pathogenesis of lymphadenopathy. Am J Pathol 1986;125:436-442.
8. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, and Markowitz M: Rapid turnover of plasma virions and CD4 lym-phocytes in HIV-1 infection. Nature (London) 1995;373:123-126.
9. Kelsoe G: Life and death in germinal centers. Immunity 1996;4:107-111.
10. Liu Y-J, Johnson GD, Gordon J, and MacLennan ICM: Germinal centers in T-cell-dependent antibody responses. Immunol Today 1992;13:17-21.
11. Liu Y-J and Banchereau J: The paths and molecular controls of peripheral B-cell development. Immunologist 1996;4:55-76.
12. Grouard G, Durand I, Filgueira L, Banchereau J, and Liu Y-J: Dendritic cells capable of stimulating T cells in germinal centres. Nature (London) 1996;384:364-367.
13. Bowen MB, Butch AW, Parvin CA, Levine A, and Nahm MH: Germinal center T cells are distinct helper-inducer T cells. Hum Immunol 1991;31:67-75.
14. Fuller KA, Kanagawa O, and Nahm MH: T cells within germinal centers are specific for the immunizing antigen. J Immunol 1993;151:4505-4512.
15. June CH, Bluestone JA, Nadler LM, and Thompson CB: The B7 and CD28 receptor families. Immunol Today 1994;15:321-331.
16. Boussiotis VA, Freeman GJ, Gribben JG, and Nadler LM: The role of B7-1/B7-2:CD28/CTLA4 pathways in the prevention of anergy, induction of productive immunity and down-regulation of the immune response. Immunol Rev 1996;153:5-26.
17. L. Immunity 1995;3:87-98.
18. Linsley PS, Brady W, Grosmaire L, Aruffo A, Damle NK, and Ledbetter JA: Binding of the B cell activation antigen B7 to CD28 costimulate T cell proliferation and interleukin 2 mRNA accumulation. J Exp Med 1991;173:721-730.
19. Chambers CA, Krummel MF, Boitel B, Hurwitz A, Sullivan TJ, Fournier S, Cassell D, Brunner M, and Allison JP: The role of CTLA-4 in the regulation and initiation of T-cell responses. Immunol Rev 1996;153:27-46.
20. Walunas TL, Bakker CY, and Bluestone JA: CTLA-4 ligation blocks CD28 dependent T cell activation. J Exp Med 1996;1 83:2541-2550.
21. Azuma M, Ito D, Yagita H, Okomura K, Phillips JH, Lanier LL, and Somoza C: B70 antigen is a second ligand for CTLA-4 and CD28. Nature (London) 1993;366:76-79.
22. Fergusson SE, Han S, Kelsoe G, and Thompson CB: CD28 is required for germinal center formation. J Immunol 1996;156: 4576-4581.
23. Pantaleo G, Cohen OJ, Schwartzentruber DJ, Graziosi C, Vaccarezza M, and Fauci AS: Pathogenic insights from studies of rymphoid tissue from HIV-1-infected individuals. J Acquir Immune Defic Syndr 1995;10(Suppl. 1):S6-S14.
24. Pantaleo G, Menzo S, Vaccarezza M, Graziosi C, Cohen OJ, Demarest JF, Montefiori D, Orenstein JM, Fox C, Schräger LK, Margolick JB, Buchbinder S, Giorgi JV, and Fauci AS: Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N Engl J Med 1995;332:209-216.
25. Hufert FT, van Luzen J, Janossy G, Bertram S, Schmitz J, Haller O, Racz P, and von Laer D: Germinal center CD4+ T cells are an important site of HIV replication in vivo. AIDS 1997; 11:849-857.
26. Amadori A and Chieco-Bianchi L: B-cell activation and HIV-1 infection: Deeds and misdeeds. Immunol Today 1990;11:374-379.
27. H4 genes in AIDS-associated B-cell lymphoma. Blood 1996;88:252-260.
28. Rolling C, Treton D, Beckmann P, Galanaud P, and Richard Y: JAK3 associates with the human interleukin 4 receptor and is tyrosine phosphorylated following receptor triggering. Oncogene 1995;10:1757-1761.
29. Yokochi T, Holly RD, and Clark EA: B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus activated B cell blasts, B lymphoid lines, and Burkitt's lymphomas. J Immunol 1982; 128:823-827.
30. Barré-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, Vezinet-Brun F, Rouzioux C, Rozenbaum W, and Montagnier L: Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983;220:868-871.
31. Weissman D, Daucher J, Barker T, Adelsberger J, Baseler M, and Fauci AS: Cytokine regulation of HIV-1 replication induced by dendritic cell-CD4-positive T cell interactions. AIDS Res Hum Retroviruses 1996;12:759-767.
32. Pinchuk LM, Polacino PS, Agy MB, Klaus SJ, and Clark EA: The role of CD40 and CD80 accessory cell molecules in dendritic cell-dependent HIV-1 infection. Immunity 1994;1:317-325.
33. Pope M, Gezelter S, Gallo N, Hoffman L, and Steinman RM: Low levels of HIV-1 infection in cutaneous dendritic cells promote extensive viral replication upon binding to memory CD4+ T cells. J Exp Med 1995;182:2045-2056.
34. Kinter AL, Poli G, Fox L, Hardy E, and Fauci AS: HIV replication in IL-2-stimulated peripheral blood mononuclear cells is driven in an autocrine/paracrine manner by endogenous cytokines. J Immunol 1995;154:2448-2459.
35. Lenschow DJ, Walunas TL, and Bluestone JA: CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996;14:233-258.
36. Kuchroo VK, Prabhu Das M, Brown JA, Ranger AM, Zamvil SS, Sobel RA, Weiner HL, Nabavi N, and Glimcher LH: B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy. Cell 1995;80:707-718.
37. Freeman GJ, Boussiotis VA, Anumanthan A, Bernstein GM, Ke X-Y, Rennert PD, Gray GS, Gribben JG, and Nadler LM: B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 1995;2:523-532.
38. Reiser H and Stadecker MG: Costimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases. N Engl J Med 1996;335:1369-1377.
39. Vyth-Dreese FA, Dellemijn TAM, Majoor D, and de Jong D: Localization in situ of the co-stimulatory molecules B7.1, B7.2, CD40 and their ligands in normal human lymphoid tissue. Eur J Immunol 1995;25:3023-3029.
40. Wolthers KC, Otto SA, Lens SMA, Kolbach DN, van Lier RAW, Miedema F, and Meyaard L: Increased expression of CD80, CD86 and CD70 on T cells from HIV-1-infected individuals upon activation in vitro: Regulation of CD4+ T cells. Eur J Immunol 1996;26:1700-1706.
41. Wyss-Coray T, Mauri-Hellweg D, Baumann K, Bettens F, Grunow R, and Pichler WJ: The B7 adhesion molecule is expressed on activated human T cells: Functional involvement in T-T cell interactions. Eur J Immunol 1993;23:2175-2180.
42. Haffar OK, Smithgall MD, Wong JPG, Bradshaw J, and Linsley PS: Human immunodeficiency virus type 1 infection of CD4+ T cells down regulates the expression of CD28: effect on T cell activation and cytokine production. Clin Immunol Immunopathol 1995;77:262-270.
43. Asjo B, Cefai D, Debre P, Dudoit Y, and Autran B: A novel mode of human immunodeficiency virus type 1 (HIV-1) activation: Ligation of CD28 alone induces HIV-1 replication in naturally infected lymphocytes. J Virol 1993;67:4395-4398.
44. Tong-Starksen SE, Luciw PA, and Peterlin BM: Signaling through T lymphocyte surface proteins, TCR/CD3 and CD28, activates the HIV-1 long terminal repeat. J Immunol 1989;142:702-707.
45. Greene WC, Bohnlein E, and Ballard DW: HIV-1, HTLV-1 and normal T-cell growth: Transcriptional strategies and surprises. Immunol Today 1989;10:272-278.
46. Viola A and Lanzavecchia A: T cell activation determined by T cell receptor number and tunable thresholds. Science 1996; 273:104-106.
47. Rudd CE: Upstream-downstream: CD28 cosignaling pathways and T cell function. Immunity 1996;4:527-534.
48. Smithgall MD, Wong JGP, Critchett KE, and Haffar OK: IL-7 upregulates HIV-1 replication in naturally infected peripheral blood mononuclear cells. J Immunol 1996;156:2324-2330.